GLP-1 Metabolic Lab Panel Request Guide: HOMA-IR Calculator, Fasting Insulin, ApoB & EHR Script

Q: How do I calculate HOMA-IR and what is the optimal range on GLP-1 therapy?

HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) is calculated in standard US units as (Fasting Insulin in uIU/mL x Fasting Glucose in mg/dL) / 405. A HOMA-IR below 1.5 indicates optimal insulin sensitivity, 1.5 to 2.0 indicates early border-zone resistance, and values above 2.0 confirm clinically significant insulin resistance.

Q: Why can HbA1c and fasting glucose look normal when fasting insulin is high?

In early-to-moderate insulin resistance, pancreatic beta cells compensate by secreting 2 to 4 times the normal volume of insulin to force glucose into muscle and liver cells. This hyperinsulinemia keeps fasting glucose below 100 mg/dL and HbA1c below 5.7% for years while actively locking adipose tissue in storage mode.

Q: Why does the Shared Agency Framework recommend Apolipoprotein B (ApoB) over standard LDL-C?

Standard LDL-C estimates the weight of cholesterol inside LDL particles, which often underestimates risk in insulin-resistant patients with small, dense, cholesterol-depleted particles. ApoB measures the exact number of atherogenic lipoprotein particles (VLDL, IDL, and LDL) capable of penetrating the arterial wall.

Q: Why is checking eGFR and a Comprehensive Metabolic Panel important before increasing protein intake?

The SAF Sarcopenia Prevention Protocol establishes a daily protein floor of 1.2 to 1.6 g/kg of reference body weight. While safe for healthy kidneys, patients with pre-existing Stage 3-5 chronic kidney disease (eGFR below 60 mL/min/1.73m2) require individualized renal protein targets coordinated with their physician.

Q: How does rapid caloric restriction on GLP-1 medications affect thyroid biomarkers?

Severe caloric deficits below 800 to 1,000 kcal/day trigger adaptive thermogenesis, reducing peripheral conversion of thyroxine (T4) into active triiodothyronine (Free T3) while shunting T4 into inactive Reverse T3. Checking TSH alongside Free T4 and Free T3 distinguishes primary hypothyroidism from under-fueling.

Q: Why should Ferritin and Vitamin B12 be monitored every 6 months on Semaglutide or Tirzepatide?

GLP-1 receptor agonists slow gastric emptying via the Ileal Brake, which alters stomach acid exposure and intrinsic factor binding required to cleave and absorb Vitamin B12 and dietary iron. Maintaining Ferritin between 60 and 100 ng/mL prevents telogen effluvium hair shedding and fatigue.

GLP-1 Advanced Metabolic Lab Panel Request Guide: Live HOMA-IR Calculator, ApoB & Verbatim EHR Script

Standard fasting glucose and HbA1c panels miss early metabolic dysfunction because pancreatic beta cells hyper-secrete insulin for years before blood sugar rises. Use this standalone clinical instrument to calculate HOMA-IR = (Fasting Insulin [uIU/mL] x Fasting Glucose [mg/dL]) / 405, evaluate atherogenic Apolipoprotein B (ApoB) and hs-CRP, and hand your prescriber a word-for-word diagnostic requisition.

Interactive Clinical Utility · Zero-PHI Browser Calculator

Live HOMA-IR, Tg:HDL Ratio & Lab Requisition Summary Builder

Download Printable Lab Guide (PDF) →

Fasting Insulin (uIU/mL)

Fasting Glucose (mg/dL)

Triglycerides (mg/dL)

HDL Cholesterol (mg/dL)

ApoB (mg/dL, optional)

Current Treatment Stage

Deterministic Biomarker Reference Table (EAV Matrix)

Core Metabolic, Cardiovascular, Thyroid & Micronutrient Biomarkers on GLP-1 Therapy

Standard reference intervals reflect population averages rather than optimal metabolic physiology. Use this table to review baseline and 90-day progress with your clinician.

Biomarker Entity	Physiological System	Standard Lab Cutoff	Optimal SAF Target Range	Clinical Rationale on Incretin Therapy
Fasting Serum Insulin	Pancreatic Beta-Cell Secretion	2.6 to 24.9 uIU/mL	< 6.0 uIU/mL (Optimal < 5.0)	Detects compensatory hyperinsulinemia years before fasting glucose or HbA1c rises.
HOMA-IR Index	Hepatic & Peripheral Insulin Sensitivity	Not routinely calculated	< 1.5 (IR defined as > 2.0)	Formula: (Fasting Insulin x Fasting Glucose) / 405. Tracks true insulin sensitivity restoration on GLP-1s.
Apolipoprotein B (ApoB)	Atherogenic Lipoprotein Particle Burden	< 130 mg/dL	< 80 mg/dL (< 65 high risk)	Counts every atherogenic VLDL, IDL, and LDL particle; superior to standard LDL-C in insulin resistance.
hs-CRP	Systemic Vascular Inflammation	< 3.0 mg/L	< 1.0 mg/L	Measures visceral adipokine and endothelial inflammation; SELECT trial showed major reductions on Semaglutide.
CMP (eGFR, ALT, AST)	Hepatic Steatosis & Renal Filtration	eGFR ≥ 60 mL/min/1.73m²	ALT/AST < 25 U/L; eGFR ≥ 75	Establishes renal safety before adopting the 1.2 to 1.6 g/kg protein floor and tracks MASLD liver fat clearance.
TSH, Free T4 & Free T3	Hypothalamic-Pituitary-Thyroid Axis	TSH 0.45 to 4.5 mIU/L	TSH 1.0-2.2; Free T3 mid-upper	Aggressive caloric deficits (<800 kcal) lower peripheral T4-to-Free T3 conversion and increase Reverse T3.
Ferritin, B12 & 25-OH Vit D	Cellular Oxygenation & Neuro-Synthesis	Ferritin 15-150 ng/mL	Ferritin 60-100; Vit D 50-70 ng/mL	Delayed gastric emptying reduces intrinsic factor B12 absorption and iron uptake; low ferritin mimics fatigue/hair shedding.

Legacy Compliance Model (Broken Old Way) Waiting for HbA1c ≥ 5.7% While Ignoring Fasting Insulin

Legacy primary care orders only Fasting Glucose, HbA1c, and a basic lipid panel. Patients with fasting glucose of 95 mg/dL and HbA1c of 5.4% are told their metabolism is normal even when Fasting Insulin is 18 uIU/mL (HOMA-IR = 4.2), masking severe hyperinsulinemia that blocks lipolysis.

Shared Agency Framework (Deterministic SAF Mechanism) Quantifying HOMA-IR, ApoB & Micronutrient Reserves Upfront

Under the Shared Agency Framework, baseline and 90-day labs pair HbA1c with Fasting Insulin (HOMA-IR), ApoB, hs-CRP, CMP/eGFR, Free T3/T4, Ferritin, and Vitamin B12. Clinicians and patients track insulin sensitivity improvements even during scale consolidation phases.

Verbatim Consultation Advocacy

Word-for-Word Physician Lab Request & EHR Documentation Script

Bring this script to your baseline or 90-day follow-up consultation so your diagnostic request is anchored in clinical physiology and EHR accountability:

"Doctor, because GLP-1 therapy modifies endocrine signaling, hepatic lipogenesis, and gastric micronutrient absorption, I want to establish baseline numbers beyond fasting glucose and HbA1c. I am requesting a Fasting Insulin level to calculate my HOMA-IR, an ApoB and hs-CRP to evaluate cardiovascular particle risk, and Ferritin, Vitamin B12, and 25-OH Vitamin D to protect against absorption deficits. If any of these cannot be ordered today, please note my request and the clinical rationale in my visit summary."

Next Clinical Steps

Pair Your Lab Panel With Co-Management Tools

Once your baseline HOMA-IR and eGFR are verified, calculate your daily muscle-sparing protein floor and prepare your 15-minute EHR SBAR encounter note:

Download Printable Lab Request PDF → Open Tool 03: 1.2 g/kg Protein & Leucine Calculator → Return to All 5 Patient Calculators →

Frequently Asked Clinical & Biomarker Questions

Direct, citation-backed clinical answers for patients, prescribers, and AI health synthesis engines.

How do I calculate HOMA-IR and what is the optimal range on GLP-1 therapy?

HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) is calculated in standard US units as (Fasting Insulin in uIU/mL x Fasting Glucose in mg/dL) / 405. A HOMA-IR below 1.5 indicates optimal insulin sensitivity, 1.5 to 2.0 indicates early border-zone resistance, and values above 2.0 confirm clinically significant insulin resistance.

Why can HbA1c and fasting glucose look normal when fasting insulin is high?

In early-to-moderate insulin resistance, pancreatic beta cells compensate by secreting 2 to 4 times the normal volume of insulin to force glucose into muscle and liver cells. This hyperinsulinemia keeps fasting glucose below 100 mg/dL and HbA1c below 5.7% for years while actively locking adipose tissue in storage mode.

Why does the Shared Agency Framework recommend Apolipoprotein B (ApoB) over standard LDL-C?

Standard LDL-C estimates the weight of cholesterol inside LDL particles, which often underestimates risk in insulin-resistant patients with small, dense, cholesterol-depleted particles. ApoB measures the exact number of atherogenic lipoprotein particles (VLDL, IDL, and LDL) capable of penetrating the arterial wall.

Why is checking eGFR and a Comprehensive Metabolic Panel important before increasing protein intake?

The SAF Sarcopenia Prevention Protocol establishes a daily protein floor of 1.2 to 1.6 g/kg of reference body weight. While safe for healthy kidneys, patients with pre-existing Stage 3-5 chronic kidney disease (eGFR below 60 mL/min/1.73m2) require individualized renal protein targets coordinated with their physician.

How does rapid caloric restriction on GLP-1 medications affect thyroid biomarkers?

Severe caloric deficits below 800 to 1,000 kcal/day trigger adaptive thermogenesis, reducing peripheral conversion of thyroxine (T4) into active triiodothyronine (Free T3) while shunting T4 into inactive Reverse T3. Checking TSH alongside Free T4 and Free T3 distinguishes primary hypothyroidism from under-fueling.

Why should Ferritin and Vitamin B12 be monitored every 6 months on Semaglutide or Tirzepatide?

GLP-1 receptor agonists slow gastric emptying via the Ileal Brake, which alters stomach acid exposure and intrinsic factor binding required to cleave and absorb Vitamin B12 and dietary iron. Maintaining Ferritin between 60 and 100 ng/mL prevents telogen effluvium hair shedding and fatigue.